The partnership seeks to improve the interoperability of CDISC standards and WHODrug Global for more effective sharing and use of medicinal product safety data.

Medicine safety monitoring applies to all aspects of drug development, but how much is it impacted by patient diversity and study type in clinical trials?

Undaunted by the pandemic, the team at Instituto Nacional de Cardiología Ignacio Chávez (Mexico) established a PV centre and a follow-up unit with direct, daily clinical impact.